PharmAbcine to participate in "BIO International Convention 2023"
- Written by PR Newswire
![]() |
DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in the upcoming BIO International Convention 2023.
Details of the events are as follows:
Event: Event:...
Read more: PharmAbcine to participate in "BIO International Convention 2023"